NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.

A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...

Add Yahoo as a preferred source to see more of our stories on Google. Currently, to treat conditions such as leukaemia, damaged blood cells need to be replaced in a stem cell transplant. But ...

The human blood system is in a constant state of turnover. First-line immune defenders, like neutrophils, need to be replaced after just four to eight hours, platelets can last a week, red blood cells ...

How does blood age? A new study identifies the MLKL protein as a non-lethal driver of hematopoietic stem cell aging via ...